Kana Miyazaki

2.1k citations
46 papers · 403 indexed · h-index 12
Topics
Lymphoma Diagnosis and Treatment (31 papers)CNS Lymphoma Diagnosis and Treatment (12 papers)Viral-associated cancers and disorders (9 papers)

In The Last Decade

Kana Miyazaki

42 papers receiving 391 citations

Peers

Kana Miyazaki
Comparison fields: 5 of 57
  • Pathology and Forensic Medicine 285
  • Oncology 228
  • Neurology 97
  • Genetics 95
  • Immunology 86
Replace Sonia González de Villambrosía with:
Sonia González de Villambrosía Spain
Jiaqin Yan China
Ken Ohmachi Japan
Ronald Boonstra Netherlands
Akito Dobashi Japan
Narittee Sukswai Thailand
Teeraya Puavilai Thailand
Jennifer L. Cultrera United States
Kana Miyazaki relative to Sonia González de Villambrosía Spain Sonia González de Villambrosía's profile →
Citations per field
00.5×1.5×
Sonia González de Villambrosía · 1×
Citations per year

Countries citing papers authored by Kana Miyazaki

Since Specialization
Citations

This map shows the geographic impact of Kana Miyazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kana Miyazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kana Miyazaki more than expected).

Fields of papers citing papers by Kana Miyazaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kana Miyazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kana Miyazaki. The network helps show where Kana Miyazaki may publish in the future.

Co-authorship network of co-authors of Kana Miyazaki

This figure shows the co-authorship network connecting the top 25 collaborators of Kana Miyazaki. A scholar is included among the top collaborators of Kana Miyazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kana Miyazaki. Kana Miyazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 0
4 2
5 1
6 1
7 2
8 3
9 6
10 17
11 6
12 15
13 1
14 17
15 48
16 90
17 4
18 37
19 7
20 17

About Kana Miyazaki

Kana Miyazaki is a scholar working on Pathology and Forensic Medicine, Genetics and Neurology, having authored 46 papers that have together received 403 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (31 papers), CNS Lymphoma Diagnosis and Treatment (12 papers) and Viral-associated cancers and disorders (9 papers). The work is most often cited by research in Pathology and Forensic Medicine (285 citations), Genetics (95 citations) and Oncology (228 citations). Kana Miyazaki has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Motoko Yamaguchi, Naoyuki Katayama, Hiroshi Shiku, Hiroshi Imai, Satoshi Tamaru, Tohru Kobayashi, Ritsuro Suzuki, Hiromichi Yamane, M Kashimura and Kyoko Kobayashi. Their work appears in journals such as Journal of Clinical Oncology, Blood and The Journal of Physical Chemistry B.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026